Table 1 Clinical characteristics of cirrhotic patients with PVT
From: Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome
Total | Acute type | Chronic type | p | |
|---|---|---|---|---|
Number of patients | 90 | 27 | 63 | |
Age (years)a | 68 (37–84) | 62 (37–77) | 70 (45–84) | 0.0034 |
Male sex | 47 | 16 | 31 | 0.1885 |
BMI (kg/cm2)a | 23.0 (16.2–36.5) | 23.9 (16.2–31.5) | 22.9 (18.1–36.5) | 0.1253 |
Etiology (hepatitis C viral infection) | 61 | 19 | 42 | 0.3445 |
Clinical findings | ||||
Hepatic encephalopathy (+) | 5 | 2 | 3 | 0.7748 |
Ascites (+) | 39 | 11 | 28 | 0.9955 |
Esophagogastric varices (+) | 70 | 13 | 57 | 0.0000 |
HCC (+) | 40 | 1 | 39 | 0.0000 |
Duration of DS treatment (14/28 days) | 61/24 | 18/6 | 43/18 | 0.6042 |
Child-Pugh score | 7 (5–12) | 7 (5–10) | 8 (5–12) | 0.0143 |
Platelet count (μl) | 8.0 (1.7–65.5) | 20.0 (3.9–65.5) | 7.1 (1.7–21.7) | 0.0000 |
Serum albumin (g/dL) | 3.1 (2.1–4.5) | 3.1 (2.7–4.5) | 3.2 (2.1–4.4) | 0.5181 |
Total bilirubin (mg/dL) | 1.3 (0.4–5.4) | 0.9 (0.4–3.9) | 1.5 (0.5–5.4) | 0.0000 |
Aspartate aminotransferase (IU/L) | 39 (15–177) | 36 (17–103) | 41 (15–177) | 0.0427 |
Alanine aminotransferase (IU/L) | 23 (0–119) | 22 (11–78) | 23 (0–119) | 0.9222 |
NH3 (μg/dL) | 70 (21–185) | 44 (22–136) | 78 (21–185) | 0.0064 |
Prothrombin time (%) | 68.3 (27.8–95.3 | 73.8 (50.0–85.6) | 65.0 (27.8–95.3) | 0.1010 |
Prothrombin time -INR | 1.23 (1.02–2.03) | 1.19 (1.08–1.38) | 1.24 (1.02–2.03) | 0.1059 |
Indocyanine green (%) | 38 (2–78) | 25 (2–56) | 41 (22–78) | 0.0024 |